Sponsor:
Quince Therapeutics S.p.A.
Code:
NCT06193200
Conditions
Ataxia Telangiectasia
Eligibility Criteria
Sex: All
Age: 6+
Healthy Volunteers: Not accepted
Interventions
Dexamethasone sodium phosphate
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Quince Therapeutics S.p.A. on 2025-05-01.